Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achievement of Reactor-Relevant Performance in Negative Triangularity Shape in the DIII-D Tokamak.

Physical review letters·2019
Same author

Tokamak operation with safety factor q95 < 2 via control of MHD stability.

Physical review letters·2014
Same author

Sustained stabilization of the resistive-wall mode by plasma rotation in the DIII-D tokamak.

Physical review letters·2002
Same author

Metastatic carcinoma masquerading as primary carcinoma.

Canadian journal of surgery. Journal canadien de chirurgie·2000
Same author

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

The New England journal of medicine·1999
Same author

Improved method for transjugular liver biopsy.

Journal of vascular and interventional radiology : JVIR·1999

Related Experiment Video

Updated: Jul 17, 2026

The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

Liver resection for colorectal metastases

Y Fong1, A M Cohen, J G Fortner

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. FongY@msKcc.org

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|March 1, 1997
PubMed
Summary

Liver resection for colorectal metastases is safe and effective, offering the only potential cure for metastatic colorectal cancer. Extrahepatic disease is the sole contraindication, making resection standard for eligible patients.

More Related Videos

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
04:22

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

Related Experiment Videos

Last Updated: Jul 17, 2026

The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
04:22

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

Area of Science:

  • Surgical Oncology
  • Hepatobiliary Surgery
  • Colorectal Cancer Metastasis

Background:

  • Colorectal cancer frequently metastasizes to the liver, affecting over 50,000 patients annually in the US.
  • Effective treatment options for liver metastases are crucial for improving patient outcomes.

Purpose of the Study:

  • To assess the safety and efficacy of liver resection for colorectal metastases.
  • To identify predictors of outcomes following liver resection for metastatic colorectal cancer.

Main Methods:

  • Analysis of data from 456 consecutive liver resections for colorectal metastases.
  • Study period: July 1985 to December 1991 at a tertiary referral center.

Main Results:

  • Perioperative mortality was 2.8% (4.6% for major resections). Median hospital stay was 12 days.
  • 5-year survival rate was 38%, with a median survival of 46 months.
  • Predictors of poorer outcome included positive margin, large tumor size (>10 cm), short disease-free interval (<12 months), multiple tumors, and extrahepatic disease.

Conclusions:

  • Liver resection is a safe and effective therapy, representing the only potentially curative option for metastatic colorectal cancer.
  • Extrahepatic disease is the only absolute contraindication for resection.
  • Liver resection should be considered standard therapy for fit patients with liver-limited colorectal metastases.